Literature DB >> 20148361

Diabetes and risk of incident cancer: a large population-based cohort study in Israel.

Gabriel Chodick1, Anthony D Heymann, Lena Rosenmann, Manfred S Green, Shira Flash, Avi Porath, Ehud Kokia, Varda Shalev.   

Abstract

Type 2 diabetes mellitus has been associated with an increased risk of a variety of cancers in observational studies, but few have reported the relationship between diabetes and cancer risk in men and women separately. The main goal of this retrospective cohort study was to evaluate the sex-specific risk of incident overall and site-specific cancer among people with DM compared with those without, who had no reported history of cancer at the start of the follow-up in January 2000. During an average of 8 years of follow-up (SD = 2.5), we documented 1,639 and 7,945 incident cases of cancer among 16,721 people with DM and 83,874 free of DM, respectively. In women, DM was associated with an adjusted hazard ratio of 1.96 (95% CI: 1.53-2.50) and 1.41 (95% CI: 1.20-1.66) for cancers of genital organs and digestive organs, respectively. A significantly reduced HR was observed for skin cancer (0.38; 95% CI: 0.22-0.66). In men with DM, there was no significant increase in overall risk of cancer. DM was related with a 47% reduction in the risk of prostate cancer. These findings suggest that the nature of the association between DM and cancer depends on sex and specific cancer site.

Entities:  

Mesh:

Year:  2010        PMID: 20148361     DOI: 10.1007/s10552-010-9515-8

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  49 in total

1.  Diabetes and risk of esophageal and gastric adenocarcinomas.

Authors:  Xuejuan Jiang; Leslie Bernstein; Chiu-Chen Tseng; Anna H Wu
Journal:  Int J Cancer       Date:  2012-01-11       Impact factor: 7.396

Review 2.  Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies.

Authors:  Ying Jiang; Qiwen Ben; Hong Shen; Weiqi Lu; Yong Zhang; Jun Zhu
Journal:  Eur J Epidemiol       Date:  2011-09-22       Impact factor: 8.082

Review 3.  Diabetes mellitus is an independent risk factor for colorectal cancer.

Authors:  Lei Sun; Shiying Yu
Journal:  Dig Dis Sci       Date:  2012-06       Impact factor: 3.199

Review 4.  The complexities of obesity and diabetes with the development and progression of pancreatic cancer.

Authors:  Bin Bao; Zhiwei Wang; Yiwei Li; Dejuan Kong; Shadan Ali; Sanjeev Banerjee; Aamir Ahmad; Fazlul H Sarkar
Journal:  Biochim Biophys Acta       Date:  2010-12-01

5.  Diabetes and thyroid cancer risk in the National Institutes of Health-AARP Diet and Health Study.

Authors:  Briseis Aschebrook-Kilfoy; Mona M Sabra; Alina Brenner; Steven C Moore; Elaine Ron; Arthur Schatzkin; Albert Hollenbeck; Mary H Ward
Journal:  Thyroid       Date:  2011-07-18       Impact factor: 6.568

Review 6.  Metformin may function as anti-cancer agent via targeting cancer stem cells: the potential biological significance of tumor-associated miRNAs in breast and pancreatic cancers.

Authors:  Bin Bao; Asfar S Azmi; Shadan Ali; Feras Zaiem; Fazlul H Sarkar
Journal:  Ann Transl Med       Date:  2014-06

7.  Clinical benefits of metformin in gynecologic oncology.

Authors:  Atsushi Imai; Satoshi Ichigo; Kazutoshi Matsunami; Hiroshi Takagi; Keigo Yasuda
Journal:  Oncol Lett       Date:  2015-05-25       Impact factor: 2.967

8.  Intensive glucose control and risk of cancer in patients with type 2 diabetes.

Authors:  G Stefansdottir; S Zoungas; J Chalmers; A P Kengne; M J Knol; H G M Leufkens; A Patel; M Woodward; D E Grobbee; M L De Bruin
Journal:  Diabetologia       Date:  2011-04-21       Impact factor: 10.122

Review 9.  Pre-existing diabetes mellitus increases the risk of gastric cancer: a meta-analysis.

Authors:  Jae Moon Yoon; Ki Young Son; Chun Sick Eom; Daniel Durrance; Sang Min Park
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

10.  Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium.

Authors:  Joanne W Elena; Emily Steplowski; Kai Yu; Patricia Hartge; Geoffrey S Tobias; Michelle J Brotzman; Stephen J Chanock; Rachael Z Stolzenberg-Solomon; Alan A Arslan; H Bas Bueno-de-Mesquita; Kathy Helzlsouer; Eric J Jacobs; Andrea LaCroix; Gloria Petersen; Wei Zheng; Demetrius Albanes; Naomi E Allen; Laufey Amundadottir; Ying Bao; Heiner Boeing; Marie-Christine Boutron-Ruault; Julie E Buring; J Michael Gaziano; Edward L Giovannucci; Eric J Duell; Göran Hallmans; Barbara V Howard; David J Hunter; Amy Hutchinson; Kevin B Jacobs; Charles Kooperberg; Peter Kraft; Julie B Mendelsohn; Dominique S Michaud; Domenico Palli; Lawrence S Phillips; Kim Overvad; Alpa V Patel; Leah Sansbury; Xiao-Ou Shu; Michael S Simon; Nadia Slimani; Dimitrios Trichopoulos; Kala Visvanathan; Jarmo Virtamo; Brian M Wolpin; Anne Zeleniuch-Jacquotte; Charles S Fuchs; Robert N Hoover; Myron Gross
Journal:  Cancer Causes Control       Date:  2012-10-31       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.